Skip to search formSkip to main contentSkip to account menu

gp100(280-288) melanoma antigen peptide

Known as: Tyr-Leu-Glu-Pro-Gly-Pro-Val-Thr-Ala, YLEPGPVTA, tyrosyl-leucyl-glutamyl-prolyl-glycyl-prolyl-valyl-threonyl-alanine 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Peptidesgp100 Melanoma Antigen

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Competition Among Peptides in Melanoma Vaccines for Binding to MHC Molecules
The effectiveness of peptide-based cancer vaccines depends on the ability of peptides to bind to MHC molecules on the surface of… 
2004
2004
Degradation of the tumor antigen epitope gp100(280-288) by fibroblast-associated enzymes abolishes specific immunorecognition.
2003
2003
Degradation of the immunogenic peptide gp100280–288 by the monocyte-like U937 cell line
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)